6
Views
0
CrossRef citations to date
0
Altmetric
Original Article

A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness

, , , , &
Pages 49-55 | Published online: 06 Jul 2009

References

  • Lemberger L, Fuller R W, Zerbe R L. Use of specific serotonin uptake inhibitors as antidepressants. Clinical Neuropharmacology 1985; 8: 299–317
  • Wong D, Bymaster F P, Horng J S, Molloy B B. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethyl phenoxy)-N-methyl-3-phenyl propylamine. Journal of Pharmacology and Experimental Therapeutics 1975; 193: 804–811
  • Schmidt M J, Fuller R W, Wong D T. Fluoxetine, a highly selective serotonin reuptake inhibitor: a review of preclinical studies. British Journal of Psychiatry 1988; 153(Supplement 3)40–46
  • Hall J. Fluoxetine: Efficacy against placebo and by dose- an overview. British Journal of Psychiatry 1988; 153: 59–63, (Supplement 3)
  • Levine S, Deo R, Mahadevan K. A comparative trial of a new antidepressant: fluoxetine. British Journal of Psychiatry 1987; 150: 653–655
  • Young J PR, Coleman A, Lader M H. A controlled comparison of fluoxetine and amitriptyline in depressed outpatients. British Journal of Psychiatry 1987; 151: 337–340
  • Bremner J. Fluoxetine in depressed patients: a comparison with imipramine. Journal of Clinical Psychiatry 1984; 45: 414–419
  • Cohn J B, Wilcox C. A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorders. Journal of Clinical Psychiatry 1985; 46: 26–31
  • Feighner J P, Boyer W F, Merideth C H, Hendrickson G. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression. International Clinical Psychopharmacology 1989; 4: 127–134
  • Chouinard G. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 32–37
  • Manna V., Martucci N., Agnoli A. Double-blind controlled study on the clinical efficacy and safety of fluoxetine versus clomipramine in the treatment of major depressive disorders. International Clinical Psychopharmacology 1989; 4(Supplement 1)81–88
  • Ropert R, Bouchard J M, Caroli F, Cotin M, Danic C, Barbier J E, Talgom L., Leroy J P, Rigal J, Binoux F, Delpech J, Delcourt T. Fluoxetine versus clomipramine in major depressive disorders. International Clinical Psychopharmacology 1989; 4: 89–95
  • Ginestel D, Alby J M, Besancon G, Carrier G, Cordier B, Degiovanni A, Dufour H, Ferreri M, Leger L, Moron P, Pellet J, Perivier E., Singer L., Ulliac G. Fluoxetine in endogenous depression and melancholia versus clomipramine. International Clinical Psychopharmacology 1989; 4: 37–40
  • Cooper G L. The safety of fluoxetine- an update. British Journal of Psychiatry. 1988; 153: 77–86, (Supplement 3)
  • Fawcett J, Zajecka J M, Kravitz H M, Edwards J, Jeffries H, Scorza E. Fluoxetine versus amitriptyline in adult outpatients with major depression. Current Therapeutic Research 1989; 45: 821–832
  • Feighner J P. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 369–372
  • Masco H L, Sheetz M S. Double-blind comparison of fluoxetine and amitriptyline in the treatment of major depressive illness. Advances in Therapy 1985; 2: 275–284
  • Laakmann G, Blaschke D, Engel R, Schwarz A., Fluoxetine V. Amitriptyline in Treatment of Depressed Outpatients. British Journal of Psychiatry 1988; 153(Suppl 3)64–68
  • Almatura A C, Percudani M, Guercetti G, Invernizzi G. Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitriptyline. International Clinical Psychopharmacology 1989; 4(Suppl 1)103–106
  • Judd F K. Preliminary report of a double-blind study comparing fluoxetine and amitriptyline in the treatment of depression. In: Recent Advances in the Treatment of Depression. Proceedings from a symposium in Hong Kong. JAMA SE Asia (Suppl) 1991; 6(4)
  • Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967; 6: 278–296
  • Carroll B J, Feinberg M, Smouse P E, Rawson S G., Greden J F. The Carroll Rating Scale for Depression I. Development, Reliability and Validation. British Journal of Psychiatry 1981; 138: 194–200
  • Teicher M H, Glod C, Cole J O. Emergence of intense suicidal pre-occupation during fluoxetine treatment. American Journal of Psychiatry 1990; 147: 207–10
  • Masand P, Gupta S, Dewan M. Suicidal ideation related to fluoxetine treatment. New England Journal of Medicine 1991; 324: 420
  • Clark C, Downie C C. A method for the rapid determination of the number of patients to include in a controlled clinical trial. Lancet 1966; 2: 1357–1358
  • Beasley C M, Dornseif B E, Bosomworth J C, Sayler M E, Rampey A H, Heiligenstein J H, Thompson V L, Murphy D J, Marica D N. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 1991; 303: 685–692

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.